Pharmacogenomics
Increase your PGx IQ
Harness the full power of this emerging field by understanding the implications PGx testing has on patient treatment outcomes. To educate physicians and providers about current and future PGx applications, Mayo Clinic offers a one-of-a-kind online certificate course that guides attendees through foundational pharmacogenomic concepts and advanced decision-making. Engaging lectures, expert panels, case-based presentations, and patient role-play activities educate attendees on pharmacogenetic fundamentals, test interpretation, and tips on implementing PGx into your practice. Learn more.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.
No posts available.